Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1975 1
1984 2
1990 1
1991 2
1992 1
1993 3
1995 1
1998 1
1999 2
2000 2
2001 1
2002 2
2003 1
2004 7
2005 6
2006 3
2007 2
2008 1
2009 6
2010 3
2011 5
2012 8
2013 7
2014 7
2015 9
2016 10
2017 13
2018 7
2019 9
2020 24
2021 11
2022 21
2023 10
2024 20
2025 34
2026 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Results by year

Filters applied: . Clear all
Page 1
Myasthenic crisis.
Claytor B, Cho SM, Li Y. Claytor B, et al. Muscle Nerve. 2023 Jul;68(1):8-19. doi: 10.1002/mus.27832. Epub 2023 Apr 28. Muscle Nerve. 2023. PMID: 37114503 Review.
Myasthenic crisis (MC) is a life-threatening manifestation of myasthenia gravis (MG) defined by respiratory insufficiency that requires the use of invasive or non-invasive ventilation. ...MG patients with a history of MC, severe disease, oropharyngeal weaknes …
Myasthenic crisis (MC) is a life-threatening manifestation of myasthenia gravis (MG) defined by respiratory insufficiency that …
Management of Myasthenic Crisis and Emerging Roles of Molecularly Targeted Therapies: A Narrative Review.
Takahashi S, Kinno R. Takahashi S, et al. Neurol Int. 2025 Oct 8;17(10):163. doi: 10.3390/neurolint17100163. Neurol Int. 2025. PMID: 41149784 Free PMC article. Review.
Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by fluctuating skeletal muscle weakness. Myasthenic crisis (MCr), a severe and potentially life-threatening complication, presents with respiratory failure and requires intensive care and rapid im …
Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by fluctuating skeletal muscle weakness. Myasthenic crisis …
[Myasthenic Crisis].
Stetefeld HR, Schroeter M. Stetefeld HR, et al. Fortschr Neurol Psychiatr. 2018 May;86(5):301-307. doi: 10.1055/a-0599-0811. Epub 2018 May 29. Fortschr Neurol Psychiatr. 2018. PMID: 29843179 Review. German.
At variance, the timely recognition and treatment of myasthenic exacerbation may prevent a manifesting crisis. This reviews deals with red flags that pronounce exacerbation and crisis. Myasthenic crisis is an important differential diagnosis of …
At variance, the timely recognition and treatment of myasthenic exacerbation may prevent a manifesting crisis. This reviews de …
International consensus guidance for management of myasthenia gravis: Executive summary.
Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M, Palace J, Richman DP, Verschuuren J, Narayanaswami P. Sanders DB, et al. Neurology. 2016 Jul 26;87(4):419-25. doi: 10.1212/WNL.0000000000002790. Epub 2016 Jun 29. Neurology. 2016. PMID: 27358333 Free PMC article. Review.
Definitions were developed for goals of treatment, minimal manifestations, remission, ocular MG, impending crisis, crisis, and refractory MG. An in-person panel meeting then determined 7 treatment topics to be addressed. ...RESULTS: Guidance statements were develope …
Definitions were developed for goals of treatment, minimal manifestations, remission, ocular MG, impending crisis, crisis, and …
Myasthenic crisis.
Lacomis D. Lacomis D. Neurocrit Care. 2005;3(3):189-94. doi: 10.1385/NCC:3:3:189. Neurocrit Care. 2005. PMID: 16377829 Review.
Myasthenic crisis is a serious occurrence, affecting up to 27% of patients with myasthenia gravis. In the approach to the patient with myasthenic crisis, (1) the diagnosis of myasthenia gravis is confirmed; (2) respiratory failure is evaluated and trea …
Myasthenic crisis is a serious occurrence, affecting up to 27% of patients with myasthenia gravis. In the approach to the pati …
Summary of the best evidence for the prevention and management of myasthenic crisis after thymectomy.
Chen P, Bao F, Pompeo E, Zhang X, Xu T. Chen P, et al. Gland Surg. 2024 Apr 29;13(4):540-551. doi: 10.21037/gs-24-90. Epub 2024 Apr 26. Gland Surg. 2024. PMID: 38720682 Free PMC article. Review.
BACKGROUND: Myasthenic crisis (MC) may occur after thymectomy in patients with myasthenia gravis (MG), but effective preventive interventions can reduce the occurrence of this complication. Previous research on MC focused on risk factors, emergency treatment, etc., …
BACKGROUND: Myasthenic crisis (MC) may occur after thymectomy in patients with myasthenia gravis (MG), but effective preventiv …
Myasthenia gravis: management of myasthenic crisis and perioperative care.
Juel VC. Juel VC. Semin Neurol. 2004 Mar;24(1):75-81. doi: 10.1055/s-2004-829595. Semin Neurol. 2004. PMID: 15229794 Review.
Myasthenic crisis may be defined as respiratory failure or delayed postoperative extubation for more than 24 hours resulting from myasthenic weakness. ...Myasthenic crisis should not be fatal, as long as patients receive timely respiratory suppo …
Myasthenic crisis may be defined as respiratory failure or delayed postoperative extubation for more than 24 hours resulting f …
Comparative Analysis of Intravenous Immunoglobulins (IVIg) vs Plasmapheresis (PLEX) in the Management of Myasthenic Crisis.
Zain A, Akram MS, Ashfaq F, Ans A, Ans HH. Zain A, et al. Cureus. 2024 Sep 7;16(9):e68895. doi: 10.7759/cureus.68895. eCollection 2024 Sep. Cureus. 2024. PMID: 39376877 Free PMC article. Review.
Two rapid therapies used to manage myasthenic crises are intravenous immunoglobulins (IVIg) and plasmapheresis (PLEX). ...Our article highlights the need for further research to establish definitive guidelines and enhance patient outcomes in myasthenic cri …
Two rapid therapies used to manage myasthenic crises are intravenous immunoglobulins (IVIg) and plasmapheresis (PLEX). ...Our …
Management of Juvenile Myasthenia Gravis.
O'Connell K, Ramdas S, Palace J. O'Connell K, et al. Front Neurol. 2020 Jul 24;11:743. doi: 10.3389/fneur.2020.00743. eCollection 2020. Front Neurol. 2020. PMID: 32793107 Free PMC article. Review.
First-line treatment of generalized JMG is symptomatic management with pyridostigmine, but early use of immunosuppression, where good control is not achieved is important. ...The benefit is less clear in ocular JMG and is not advised in MuSK-JMG. Children experiencing a …
First-line treatment of generalized JMG is symptomatic management with pyridostigmine, but early use of immunosuppression, where good …
Autoimmune Myasthenia Gravis.
Juel VC. Juel VC. Continuum (Minneap Minn). 2025 Oct;31(5):1270-1302. doi: 10.1212/cont.0000000000001612. Epub 2025 Oct 2. Continuum (Minneap Minn). 2025. PMID: 41037173 Review.
OBJECTIVE: This article reviews the diagnosis and management of autoimmune myasthenia gravis (MG), encompassing epidemiology, clinical features including disease heterogeneity, pathophysiology, and therapeutic approaches. ...The treatment of patients with MG with ex …
OBJECTIVE: This article reviews the diagnosis and management of autoimmune myasthenia gravis (MG), encompassing epidemiology, clinica …
243 results